-
1.发明申请Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen 审中-公开通过抑制鳞状细胞癌相关抗原的表达来治疗牛皮癣，鳞状细胞癌和/或角化不全的方法和药物组合物公开(公告)号：US20110305783A1
公开(公告)日：2011-12-15
申请号：US12907412
申请日：2010-10-19
IPC分类号： A61K36/42 , A61K36/81 , A61P17/00 , A61K36/725 , A61K36/88 , A61K36/87 , A61K36/185
CPC分类号： C12Q1/37 , A61K31/713 , A61K36/185 , A61K36/42 , A61K36/725 , A61K36/81 , A61K36/87 , A61K36/88 , G01N33/5044 , G01N2500/04 , G01N2800/20 , G01N2800/205
摘要： In a first aspect thereof, the present invention provides a method for treatment and/or prevention of a disease selected from the group consisting of psoriasis and squamous cell carcinoma by inhibiting the expression of squamous cell carcinoma antigen (SCCA) by cells. In another aspect thereof, the present invention provides a method for screening for substances that inhibit epidermal parakeratosis, wherein the activity of a candidate substance that inhibits cysteine protease inhibitory activity possessed by squamous cell carcinoma antigen 1 (SCCA-1) is used as an indicator.
摘要翻译： 在其第一方面，本发明提供了通过抑制细胞对鳞状细胞癌抗原（SCCA）的表达来治疗和/或预防选自牛皮癣和鳞状细胞癌的疾病的方法。 另一方面，本发明提供了筛选抑制表皮角化不全的物质的方法，其中抑制鳞状细胞癌抗原1（SCCA-1）具有的半胱氨酸蛋白酶抑制活性的候选物质的活性被用作指示剂 。
-
2.发明授权Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen 有权通过抑制鳞状细胞癌相关抗原的表达来治疗牛皮癣，鳞状细胞癌和/或角化不全的方法和药物组合物公开(公告)号：US07829547B2
公开(公告)日：2010-11-09
申请号：US11886475
申请日：2005-09-22
CPC分类号： C12Q1/37 , A61K31/713 , A61K36/185 , A61K36/42 , A61K36/725 , A61K36/81 , A61K36/87 , A61K36/88 , G01N33/5044 , G01N2500/04 , G01N2800/20 , G01N2800/205
摘要： In a first aspect thereof, the present invention provides a method for treatment and/or prevention of a disease selected from the group consisting of psoriasis and squamous cell carcinoma by inhibiting the expression of squamous cell carcinoma antigen (SCCA) by cells. In another aspect thereof, the present invention provides a method for screening for substances that inhibit epidermal parakeratosis, wherein the activity of a candidate substance that inhibits cysteine protease inhibitory activity possessed by squamous cell carcinoma antigen 1 (SCCA-1) is used as an indicator.
摘要翻译： 在其第一方面，本发明提供了通过抑制细胞对鳞状细胞癌抗原（SCCA）的表达来治疗和/或预防选自牛皮癣和鳞状细胞癌的疾病的方法。 另一方面，本发明提供了筛选抑制表皮角化不全的物质的方法，其中抑制鳞状细胞癌抗原1（SCCA-1）具有的半胱氨酸蛋白酶抑制活性的候选物质的活性被用作指示剂 。
-
3.发明授权Method for evaluating skin condition using squamous cell carcinoma antigen as marker 有权使用鳞状细胞癌抗原作为标记评估皮肤状况的方法公开(公告)号：US09063157B2
公开(公告)日：2015-06-23
申请号：US11886488
申请日：2006-03-17
CPC分类号： G01N33/6881 , G01N33/5005 , G01N33/5091 , G01N33/53 , G01N2800/20 , G01N2800/202 , G01N2800/205 , G01N2800/24 , G01N2800/40
摘要： The invention provides a method for evaluating skin condition using squamous cell carcinoma antigen (SCCA) expression in skin stratum corneum cells as a marker.
摘要翻译： 本发明提供了一种使用鳞状细胞癌抗原（SCCA）在皮肤角质层细胞中表达作为标记来评估皮肤状况的方法。
-
4.发明申请Method Of Evaluating Degree Of Skin Sensitivity Using Squamous Cell Carcinoma Antigen As An Indicator Thereof 审中-公开使用鳞状细胞癌抗原作为指标评估皮肤敏感度程度的方法公开(公告)号：US20090208985A1
公开(公告)日：2009-08-20
申请号：US12225181
申请日：2007-03-15
IPC分类号： G01N33/573 , C12Q1/02
CPC分类号： G01N33/6881 , G01N33/5091 , G01N2333/705
摘要： The present invention provides a method for evaluating the degree of skin sensitivity by using the expression of squamous cell carcinoma antigen (SCCA) in skin corneocytes as an indicator thereof.
摘要翻译： 本发明提供了通过使用皮肤角质细胞中的鳞状细胞癌抗原（SCCA）的表达作为其指标来评价皮肤敏感度的方法。
-
5.发明申请Method and Pharmaceutical Composition for Treating Psoriasis, Squamous Cell Carcinoma and/or Parakeratosis by Inhibiting Expression of Squamous Cell Carcinoma-Related Antigen 有权通过抑制鳞状细胞癌相关抗原表达来治疗牛皮癣，鳞状细胞癌和/或角化不全的方法和药物组合物公开(公告)号：US20090123572A1
公开(公告)日：2009-05-14
申请号：US11886475
申请日：2005-09-22
CPC分类号： C12Q1/37 , A61K31/713 , A61K36/185 , A61K36/42 , A61K36/725 , A61K36/81 , A61K36/87 , A61K36/88 , G01N33/5044 , G01N2500/04 , G01N2800/20 , G01N2800/205
摘要： In a first aspect thereof, the present invention provides a method for treatment and/or prevention of a disease selected from the group consisting of psoriasis and squamous cell carcinoma by inhibiting the expression of squamous cell carcinoma antigen (SCCA) by cells. In another aspect thereof, the present invention provides a method for screening for substances that inhibit epidermal parakeratosis, wherein the activity of a candidate substance that inhibits cysteine protease inhibitory activity possessed by squamous cell carcinoma antigen 1 (SCCA-1) is used as an indicator.
摘要翻译： 在其第一方面，本发明提供了通过抑制细胞对鳞状细胞癌抗原（SCCA）的表达来治疗和/或预防选自银屑病和鳞状细胞癌的疾病的方法。 另一方面，本发明提供了筛选抑制表皮角化不全的物质的方法，其中抑制鳞状细胞癌抗原1（SCCA-1）具有的半胱氨酸蛋白酶抑制活性的候选物质的活性被用作指示剂 。
-
公开(公告)号：US20070172444A1
公开(公告)日：2007-07-26
申请号：US11649279
申请日：2007-01-04
申请人： Toshihiko Hibino , Yumiko Tsuji , Tsutomu Soma , Sumiko Denda , Jotaro Nakanishi , Tadahito Takahashi , Kenichi Umishio , Koji Kobayashi
发明人： Toshihiko Hibino , Yumiko Tsuji , Tsutomu Soma , Sumiko Denda , Jotaro Nakanishi , Tadahito Takahashi , Kenichi Umishio , Koji Kobayashi
IPC分类号： A61K8/97 , A61K36/82 , A61K36/899 , A61K36/48 , A61K36/87
CPC分类号： A61Q5/00 , A61K8/498 , A61K8/64 , A61K8/97 , A61K31/366 , A61K36/185 , A61K36/30 , A61K36/48 , A61K36/53 , A61K36/73 , A61K36/82 , A61K36/87 , A61K36/8994 , A61K38/06 , A61K38/55 , A61K45/06 , A61K2800/782 , A61Q7/00 , A61K2300/00
摘要： There is provided a hair tonic comprising at least two of an inhibitor against 5α reductase type 2, an inhibitor against transforming growth factor β2, and an inhibitor against caspase-3; a method comprising screening for at least two of inhibition against 5α reductase type 2, inhibition against transforming growth factor β2, and inhibition against caspase-3, or comprising screening for inhibition against caspase-3 and then for apoptosis inhibition, and a hair loss inhibitor having the effect of inhibiting caspase-3, and a hair loss inhibitor having the effect of inhibiting caspase-3 and of inhibiting apoptosis.
摘要翻译： 提供了包含至少两种抑制剂5型5α还原酶2型抑制剂，抗转化生长因子β2的抑制剂和抗半胱天冬酶-3抑制剂的滋补剂; 一种方法包括筛选至少两种对2型5α还原酶的抑制，对转化生长因子β2的抑制和对半胱天冬酶-3的抑制，或包括筛选对半胱天冬酶-3的抑制，然后筛选凋亡抑制，以及脱发抑制剂 具有抑制半胱天冬酶-3的效果，以及具有抑制半胱天冬酶-3的作用并抑制细胞凋亡的脱发抑制剂。
-
公开(公告)号：US20060153794A1
公开(公告)日：2006-07-13
申请号：US11312549
申请日：2005-12-21
申请人： Toshihiko Hibino , Yumiko Tsuji , Tsutomu Soma , Sumiko Denda , Jotaro Nakanishi , Tadahito Takahashi , Kenichi Umishio , Koji Kobayashi
发明人： Toshihiko Hibino , Yumiko Tsuji , Tsutomu Soma , Sumiko Denda , Jotaro Nakanishi , Tadahito Takahashi , Kenichi Umishio , Koji Kobayashi
IPC分类号： A61K8/97 , A61K36/185
CPC分类号： A61Q5/00 , A61K8/498 , A61K8/64 , A61K8/97 , A61K31/366 , A61K36/185 , A61K36/30 , A61K36/48 , A61K36/53 , A61K36/73 , A61K36/82 , A61K36/87 , A61K36/8994 , A61K38/06 , A61K38/55 , A61K45/06 , A61K2800/782 , A61Q7/00 , A61K2300/00
摘要： There is provided a hair tonic comprising at least two of an inhibitor against 5α reductase type 2, an inhibitor against transforming growth factor β2, and an inhibitor against caspase-3; a method comprising screening for at least two of inhibition against 5α reductase type 2, inhibition against transforming growth factor β2, and inhibition against caspase-3, or comprising screening for inhibition against caspase-3 and then for apoptosis inhibition, and a hair loss inhibitor having the effect of inhibiting caspase-3, and a hair loss inhibitor having the effect of inhibiting caspase-3 and of inhibiting apoptosis.
摘要翻译： 提供了包含至少两种抑制剂5型5α还原酶2型抑制剂，抗转化生长因子β2的抑制剂和抗半胱天冬酶-3抑制剂的滋补剂; 一种方法包括筛选至少两种对2型5α还原酶的抑制，对转化生长因子β2的抑制和对半胱天冬酶-3的抑制，或包括筛选对半胱天冬酶-3的抑制，然后筛选凋亡抑制，以及脱发抑制剂 具有抑制半胱天冬酶-3的效果，以及具有抑制半胱天冬酶-3的作用并抑制细胞凋亡的脱发抑制剂。
-
公开(公告)号：US20050215509A1
公开(公告)日：2005-09-29
申请号：US11087804
申请日：2005-03-24
IPC分类号： C12N15/09 , A61K8/00 , A61K8/64 , A61K38/00 , A61K38/17 , A61K45/00 , A61K48/00 , A61P17/02 , A61P43/00 , A61Q17/04 , C12N5/10
CPC分类号： A61K38/1709 , A61K48/00
摘要： The present invention provides a method and composition that inhibit the kinase activity of JNK-1 (c-Jun N-terminal kinase 1) in cells by increasing the expression of squamous cell carcinoma antigen (SCCA) in cells.
摘要翻译： 本发明提供通过增加细胞中鳞状细胞癌抗原（SCCA）的表达来抑制细胞中JNK-1（c-Jun N-末端激酶1）的激酶活性的方法和组合物。
-
公开(公告)号：US20070160545A1
公开(公告)日：2007-07-12
申请号：US10593955
申请日：2005-03-18
申请人： Chika Katagiri , Toshihiko Hibino
发明人： Chika Katagiri , Toshihiko Hibino
CPC分类号： C07K14/47 , A61K8/606 , A61K48/00 , A61Q17/04 , G01N33/6893 , G01N2510/00 , G01N2800/20
摘要： The present invention provides a method for enhancing resistance to the onset of skin damage caused by irradiation of the skin with ultraviolet light by inhibiting ultraviolet irradiation-induced apoptosis of epidermal cells as a result of increasing expression of SCCA-1 and/or SCCA-2 in epidermal cells. Moreover, the present invention provides a skin testing method for evaluating resistance of the skin to skin damage caused by ultraviolet irradiation by measuring the expression of SCCA-1 and/or SCCA-2 in epidermal cells, and judging UV resistance of the epidermis to be weak in the case expression is decreased as compared with expression in epidermal cells. Moreover, the present invention provides a method for screening drugs which enhance resistance of the skin to skin damage by ultraviolet irradiation by selecting a drug that increases expression of SCCA-1 and/or SCCA-2 as a UV resistance enhancer.
摘要翻译： 本发明提供一种通过抑制由于SCCA-1和/或SCCA-2的表达增加而导致的表皮细胞的紫外线照射诱导的细胞凋亡而增强由紫外线照射皮肤引起的皮肤损伤发作的抗性的方法 在表皮细胞中。 此外，本发明提供了一种皮肤测试方法，用于通过测量表皮细胞中SCCA-1和/或SCCA-2的表达并评估表皮的抗紫外线性来评估由紫外线照射引起的皮肤对皮肤损伤的抗性 与表皮细胞中的表达相比，病例表达较弱。 此外，本发明提供了通过选择增加作为抗紫外线增强剂的SCCA-1和/或SCCA-2的表达的药物来增强抗紫外线照射对皮肤的皮肤损伤的药物的方法。
-
10.发明申请METHOD FOR EVALUATING STATUS OF SKIN BARRIER FUNCTION OF NATURAL MOISTURIZING FACTOR USING BLEOMYCIN HYDROLASE ACTIVITY AS INDICATOR 审中-公开使用溴霉素水解酶活性作为指示剂评价天然水分因子皮肤屏障功能状态的方法公开(公告)号：US20110165607A1
公开(公告)日：2011-07-07
申请号：US12736918
申请日：2009-05-21
申请人： Atsushi Takeda , Toshihiko Hibino
发明人： Atsushi Takeda , Toshihiko Hibino
IPC分类号： C12Q1/37
CPC分类号： C12Q1/37
摘要： The present invention provides a method for evaluating the status of the skin barrier function of natural moisturizing factor (NMF) using the activity of bleomycin hydrolase in skin tissue as an indicator.
摘要翻译： 本发明提供了一种使用博来霉素水解酶在皮肤组织中的活性作为指标来评估天然保湿因子（NMF）的皮肤屏障功能的状态的方法。
-
-
-
-
-
-
-
-
-
搜索结果
21 条记录 (耗时 0.021 秒)
